These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Practical strategies for pruritus management in the obeticholic acid-treated patient with PBC: proceedings from the 2018 expert panel. Pate J; Gutierrez JA; Frenette CT; Goel A; Kumar S; Manch RA; Mena EA; Pockros PJ; Satapathy SK; Yimam KK; Gish RG BMJ Open Gastroenterol; 2019; 6(1):e000256. PubMed ID: 30815273 [TBL] [Abstract][Full Text] [Related]
23. Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid. De Vincentis A; D'Amato D; Cristoferi L; Gerussi A; Malinverno F; Lleo A; Colapietro F; Marra F; Galli A; Fiorini C; Coco B; Brunetto M; Niro GA; Cotugno R; Saitta C; Cozzolongo R; Losito F; Giannini EG; Labanca S; Marzioni M; Marconi G; Morgando A; Pellicano R; Vanni E; Cazzagon N; Floreani A; Chessa L; Morelli O; Muratori L; Pellicelli A; Pompili M; Ponziani F; Tortora A; Rosina F; Russello M; Cannavò M; Simone L; Storato S; Viganò M; Abenavoli L; D'Antò M; De Gasperi E; Distefano M; Scifo G; Zolfino T; Calvaruso V; Cuccorese G; Palitti VP; Sacco R; Bertino G; Frazzetto E; Alvaro D; Mulinacci G; Palermo A; Scaravaglio M; Terracciani F; Galati G; Ronca V; Zuin M; Claar E; Izzi A; Picardi A; Invernizzi P; Vespasiani-Gentilucci U; Carbone M; Liver Int; 2022 Nov; 42(11):2453-2465. PubMed ID: 35932095 [TBL] [Abstract][Full Text] [Related]
24. Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection. Bowlus CL Hepat Med; 2016; 8():89-95. PubMed ID: 27621676 [TBL] [Abstract][Full Text] [Related]
25. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Hirschfield GM; Dyson JK; Alexander GJM; Chapman MH; Collier J; Hübscher S; Patanwala I; Pereira SP; Thain C; Thorburn D; Tiniakos D; Walmsley M; Webster G; Jones DEJ Gut; 2018 Sep; 67(9):1568-1594. PubMed ID: 29593060 [TBL] [Abstract][Full Text] [Related]
26. Treatment response to ursodeoxycholic acid in primary biliary cholangitis: A systematic review and meta-analysis. Gazda J; Drazilova S; Gazda M; Janicko M; Koky T; Macej M; Carbone M; Jarcuska P Dig Liver Dis; 2023 Oct; 55(10):1318-1327. PubMed ID: 36593158 [TBL] [Abstract][Full Text] [Related]
27. The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Carbone M; Sharp SJ; Flack S; Paximadas D; Spiess K; Adgey C; Griffiths L; Lim R; Trembling P; Williamson K; Wareham NJ; Aldersley M; Bathgate A; Burroughs AK; Heneghan MA; Neuberger JM; Thorburn D; Hirschfield GM; Cordell HJ; Alexander GJ; Jones DE; Sandford RN; Mells GF; Hepatology; 2016 Mar; 63(3):930-50. PubMed ID: 26223498 [TBL] [Abstract][Full Text] [Related]
28. Response Rate and Impact on Lipid Profiles of Obeticholic Acid Treatment for Patients with Primary Biliary Cholangitis: A Meta-Analysis. Gao Y; Li L; Li B; Zhan Y Can J Gastroenterol Hepatol; 2021; 2021():8829510. PubMed ID: 33511089 [TBL] [Abstract][Full Text] [Related]
30. Prognostic Value of Biochemical Response Models for Primary Biliary Cholangitis and the Additional Role of the Neutrophil-to-Lymphocyte Ratio. Yoo JJ; Cho EJ; Lee B; Kim SG; Kim YS; Lee YB; Lee JH; Yu SJ; Kim YJ; Yoon JH Gut Liver; 2018 Nov; 12(6):714-721. PubMed ID: 30400732 [TBL] [Abstract][Full Text] [Related]
31. Obeticholic acid in primary biliary cholangitis: where we stand. Manne V; Kowdley KV Curr Opin Gastroenterol; 2019 May; 35(3):191-196. PubMed ID: 30844895 [TBL] [Abstract][Full Text] [Related]
32. Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis. Soret PA; Lam L; Carrat F; Smets L; Berg T; Carbone M; Invernizzi P; Leroy V; Trivedi P; Cazzagon N; Weiler-Normann C; Alric L; Rosa-Hezode I; Heurgué A; Cervoni JP; Dumortier J; Potier P; Roux O; Silvain C; Bureau C; Anty R; Larrey D; Levy C; Pares A; Schramm C; Nevens F; Chazouillères O; Corpechot C Aliment Pharmacol Ther; 2021 May; 53(10):1138-1146. PubMed ID: 33764590 [TBL] [Abstract][Full Text] [Related]
33. Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update. Bowlus CL; Kenney JT; Rice G; Navarro R J Manag Care Spec Pharm; 2016 Oct; 22(10-a-s Suppl):S3-S15. PubMed ID: 27700211 [TBL] [Abstract][Full Text] [Related]
34. Management of primary biliary cholangitis prior to obeticholic acid availability. Durazzo M; Bonetto S; Fagoonee S; Morgando A; Pellicano R Minerva Med; 2018 Dec; 109(6):410-417. PubMed ID: 30022645 [TBL] [Abstract][Full Text] [Related]
36. What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis? Wong LL; Hegade VS; Jones DEJ Dig Dis; 2017; 35(4):359-366. PubMed ID: 28468009 [TBL] [Abstract][Full Text] [Related]